Pediatric Cefuroxime IV Dosing Recommendations
The recommended intravenous (IV) dosage of cefuroxime for pediatric patients is 100-200 mg/kg/day divided every 6-8 hours, with a maximum dose of 1500 mg per dose. 1
Dosing Guidelines by Age and Indication
Neonates and Infants
- For neonates less than 7 days old: 30 mg/kg IV every 12 hours 1
- For neonates greater than 7 days old: 30 mg/kg IV every 8 hours 1
- For infants over 1 month: 100-150 mg/kg/day divided every 6-8 hours 1
Children
- For most pediatric infections: 100-150 mg/kg/day divided every 6-8 hours 1, 2
- For severe infections: 150-200 mg/kg/day divided every 6-8 hours 1, 2
- Maximum daily dose should not exceed 6000 mg per day (1500 mg per dose) 1
Indication-Specific Dosing
Respiratory Tract Infections
- For pneumonia and other respiratory infections: 100-150 mg/kg/day divided every 8 hours 1, 3
- Some studies have shown efficacy with 75 mg/kg/day divided every 8 hours for pneumonia 3
Soft Tissue Infections
- For soft tissue infections: 75-100 mg/kg/day divided every 8 hours 4
- For severe infections: increase to 150-200 mg/kg/day 1
Intra-abdominal Infections
- For complicated intra-abdominal infections: 150 mg/kg/day divided every 6-8 hours 1
Meningitis and Severe Infections
- For bacterial meningitis: 200-240 mg/kg/day divided every 6-8 hours is recommended (though third-generation cephalosporins are generally preferred) 1, 2
Administration Considerations
- For direct intermittent IV administration, slowly inject the solution over 3-5 minutes 2
- For intermittent IV infusion, cefuroxime can be administered through Y-type administration sets 2
- Duration of therapy should be based on clinical response, typically 5-10 days for most infections 2
Dosage Adjustments
- For patients with renal impairment, dosage adjustment is necessary 2:
- Creatinine clearance >20 mL/min: standard dosing
- Creatinine clearance 10-20 mL/min: 75% of standard dose every 12 hours
- Creatinine clearance <10 mL/min: 50% of standard dose every 24 hours
Clinical Pearls and Caveats
- Cefuroxime has good activity against common pediatric pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and methicillin-sensitive Staphylococcus aureus 5, 3
- For suspected MRSA infections, additional coverage with vancomycin or clindamycin is recommended 1
- Therapeutic drug monitoring is not routinely required for cefuroxime 2
- For patients with beta-lactam allergies, alternative agents should be considered based on the severity of the allergy 1
- Studies have shown that cefuroxime achieves adequate concentrations in pleural fluid, making it suitable for respiratory infections 3
Oral Step-Down Therapy
- When switching to oral therapy, cefuroxime axetil can be used at a dose of 20-50 mg/kg/day divided every 12 hours (maximum 500 mg per dose) 1, 5
- Oral bioavailability is improved when administered with food 5
Remember that while these dosing recommendations are evidence-based, clinical judgment should be exercised based on the severity of infection, local antimicrobial resistance patterns, and patient-specific factors.